Health Sector Investors Push for Affordable Financing and Reduced Bureaucracy

Private healthcare investors in Tanzania are advocating for significant policy reforms to address persistent challenges hindering investment and service delivery. Key concerns include excessive taxation, a complex web of overlapping regulatory authorities, and prohibitively high bank interest rates. These issues, articulated by a prominent health sector investor, are seen as undermining the efficiency of private healthcare providers and impeding the government's broader goals of achieving universal health coverage and promoting local pharmaceutical production. The call for reform highlights the need for a more streamlined regulatory environment, targeted tax incentives, and mechanisms to facilitate access to affordable financing for health sector investments.

Tanzania's ambition to strengthen its healthcare sector and achieve universal health coverage is increasingly reliant on robust private sector participation. However, a recent intervention by Dr. Mahmood Mringo, a private investor in the health sector, has brought to the fore critical systemic impediments that threaten to stifle this vital contribution. Speaking at the National Public-Private Partnership (PPP) Forum on the Health Sector, Dr. Mringo highlighted three primary obstacles: excessive taxation, a labyrinth of overlapping regulatory authorities, and high bank interest rates.

These concerns underscore a tension between the government's stated policy objectives of encouraging investment, particularly in local pharmaceutical production, and the practical realities faced by private healthcare providers. The challenges articulated by Dr. Mringo are not merely operational but are deeply rooted in the existing legal and regulatory frameworks governing investment, taxation, and financial services in Tanzania. This article will delve into these legal and regulatory hurdles, examining their impact on private health sector investment and exploring the implications for practitioners and policymakers alike.

The thesis of this article is that while Tanzania has established a comprehensive legal framework for health sector regulation and investment, its implementation often results in cumulative burdens that deter private capital. Addressing these issues requires not just minor adjustments but a concerted effort to reform tax policies, rationalize regulatory mandates, and improve the transmission mechanism of monetary policy to ensure affordable credit, thereby unlocking the full potential of private investment in the health sector.

The Tanzanian legal landscape for the health sector is shaped by several key statutes and institutions. The Ministry of Health plays a central role in policy formulation and oversight. Specific regulatory functions are delegated to bodies such as the Tanzania Medicines and Medical Devices Authority (TMDA), established under the Tanzania Food, Drugs and Cosmetics Act, 2003 (Cap 219 R.E. 2023), which was later amended to the Tanzania Medicines and Medical Devices Act in 2019. The TMDA is responsible for ensuring the safety, quality, and efficacy of medicines, medical devices, and diagnostics, including premises and product registration, and conducting Good Manufacturing Practice (GMP) inspections.

Complementing this, the Medical Council of Tanganyika (MCT) operates under the Medical Practitioners and Dentists Act, Cap. 152 (2002 RE), overseeing the registration, licensing, professional conduct, and continuing professional development of medical and dental practitioners. These bodies, while distinct in their primary mandates, collectively impose a significant compliance burden on private healthcare providers. Furthermore, the broader investment climate is governed by the Tanzania Investment Act, which aims to promote and facilitate investment, though specific incentives for the health sector may require further articulation or streamlining. The government has, for instance, actively encouraged investment in local pharmaceutical production to reduce reliance on imports.

On the financial front, the Bank of Tanzania (BOT) is mandated by the Bank of Tanzania Act to formulate and implement monetary policy, primarily to maintain price stability. The Banking and Financial Institutions Act, 2006 (Cap 342 R.E. 2023), provides the overarching framework for the regulation and supervision of banks and financial institutions, granting the BOT powers over licensing, capital requirements, and permissible activities. This framework dictates the operational environment for commercial lending, including the determination of interest rates, which is a critical factor for private sector investment.

The challenges identified by Dr. Mringo – excessive taxation, overlapping regulatory authorities, and high bank interest rates – present significant legal and practical impediments to health sector investors in Tanzania. Each of these areas is governed by specific legal frameworks, yet their cumulative effect creates a disincentive for investment.

Regarding taxation, private healthcare providers face a complex and often burdensome regime. While the Value Added Tax (VAT) Act, 2014 (Cap 148 R.E. 2023), generally imposes an 18% standard rate on taxable supplies in Mainland Tanzania, certain human medicines, pharmaceuticals, medical equipment, and hospital services are exempt. However, this exemption does not always extend to raw materials and machinery, leading to high duty and VAT on inputs for local pharmaceutical manufacturing, as noted by the International Trade Administration. A recent study indicated that healthcare-related taxes and levies can add an estimated 23-38% to the final cost of healthcare delivery, effectively acting as a hidden tax on households and discouraging private investment. The Income Tax Act, Cap. 332 R.E. 2019, generally imposes a 30% corporate tax rate, which can be substantial for businesses. While the National Health Insurance Fund (NHIF) enjoys income tax exemptions on its investment returns, similar broad exemptions are not consistently applied to private health sector investors, creating an uneven playing field.

The issue of overlapping regulatory authorities, while intended to ensure public health and safety, often results in bureaucratic inefficiencies and increased compliance costs. Dr. Mringo's complaint of spending nearly a full year dealing with inspectors highlights a practical problem of coordination and potentially redundant oversight. The TMDA, under the Tanzania Medicines and Medical Devices Act, and the MCT, under the Medical Practitioners and Dentists Act, each have distinct but sometimes intersecting mandates concerning premises, personnel, and product standards. While the TMDA has achieved significant recognition for its regulatory capacity, the sheer number of inspections and reporting requirements from various bodies can divert resources from core healthcare delivery. There is a clear need for greater inter-agency coordination and possibly a single-window clearance mechanism for health sector investments to reduce administrative burdens.

Finally, the challenge of high bank interest rates is a significant barrier to capital-intensive health sector investments. The Bank of Tanzania (BOT) transitioned to an interest rate-based monetary policy framework in January 2024, introducing a Central Bank Rate (CBR) to influence short-term interest rates. However, despite an accommodative CBR (e.g., 5.75% in December 2025), commercial lending rates remain stubbornly high, averaging around 15.41%, indicating a substantial transmission gap and structural rigidities within the financial sector. This disparity means that private health investors struggle to access affordable credit, making long-term investments less viable. The Banking and Financial Institutions Act, 2006, empowers the BOT to regulate the financial sector, but market forces and perceived risks continue to drive up lending costs. The suggestion for a government guarantee scheme for health investors could mitigate some of this risk and facilitate access to more affordable loans, as advocated by Dr. Mringo.

The concerns raised by private health sector investors in Tanzania regarding excessive taxation, overlapping regulatory authorities, and high interest rates are not isolated complaints but reflect systemic issues within the country's legal and economic framework. While the government has expressed a commitment to fostering private sector growth and achieving universal health coverage, the current operational environment presents significant disincentives. The cumulative impact of various taxes, the administrative burden of navigating multiple regulatory bodies, and the prohibitive cost of capital directly undermine the viability and expansion of private healthcare services.

For legal practitioners advising clients in the Tanzanian health sector, it is crucial to conduct thorough due diligence on the specific tax implications for all aspects of a project, from importation of equipment to service delivery. Furthermore, understanding the distinct mandates and potential overlaps of regulatory bodies like the TMDA and MCT is essential for navigating the licensing and compliance landscape effectively. Practitioners should also advise on strategies to mitigate high financing costs, potentially exploring government-backed guarantee schemes or advocating for more favorable lending terms. Policymakers are urged to consider comprehensive reforms, including a review of tax incentives for health sector investments, streamlining regulatory processes through enhanced inter-agency coordination, and implementing measures to improve the transmission of monetary policy to ensure more affordable credit, thereby fostering a truly enabling environment for private healthcare investment in Tanzania.